The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis

BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective. OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuva...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatologic surgery 2020-08, Vol.46 (8), p.1054-1059
Hauptverfasser: Ellis, Morgan M., Jones, Lamont R., Siddiqui, Farzan, Sunkara, Pranit R., Ozog, David M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1059
container_issue 8
container_start_page 1054
container_title Dermatologic surgery
container_volume 46
creator Ellis, Morgan M.
Jones, Lamont R.
Siddiqui, Farzan
Sunkara, Pranit R.
Ozog, David M.
description BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective. OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuvant interventions (triple therapy). MATERIALS AND METHODSSystematic literature review and meta-analysis of combination treatment for keloids. RESULTSAfter full-text review, we included 60 articles representing 5,547 keloids5,243 received dual therapy, 259 received triple therapy, and 45 received quadruple therapy (the latter 2 groups were combined for analysis). The difference in recurrence rates between dual (19%) and triple therapy (11.2%) was not significant (p = .343). However, the difference in recurrence rates between dual therapy using surgery and radiation (18.7%) and triple therapy using surgery, radiation, and a third intervention (7.7%) was significant (p = .002). The differences for surgery and intralesional triamcinolone (TAC) showed trends toward significance, because keloids treated with dual therapy (21.7%) had a higher recurrence rate than those treated with triple therapy comprised of surgery, TAC, and another intervention (13.7%; p = .099). CONCLUSIONTriple therapy using surgery plus radiation and/or TAC as one of the adjuvant treatment modalities may achieve the lowest recurrence rates for keloids.
doi_str_mv 10.1097/DSS.0000000000002362
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_DSS_0000000000002362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32224709</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4012-5823c1c5a069e22289d0d1e00642a03443c11ec9b7da927b24b877e75ecb3f2f3</originalsourceid><addsrcrecordid>eNqFkN9u0zAUh60JxP7xBhPyC2Q7PnHqhLtqdGzaJtBariPHOaEeTlLZzkqfgNeepwJCXIBv7CN_30_2j7EzAecCKnXxYbk8hz8W5jM8YEeiQJlJhcWrdAY1y6AQeMiOQ3gEEFjl8IYd5ogoFVRH7MdqTXzRddZos-Njx5eT_5oGxxffjQ12HPhnNwU-bx-nJz1Efj-5aPuxTURSvd5YCtwOPKaclScde0pUCrolN9o2vOdzvtyFSL2O1vAHerK05Xpo-T1Fnc0H7XbBhlP2utMu0Nuf-wn7crVYXV5nd58-3lzO7zIj0-uzosTcCFNomFWUPlFWLbSCAGYSNeRSpltBpmpUqytUDcqmVIpUQabJO-zyEyb3ucaPIXjq6o23vfa7WkD90mudeq3_7jVp7_baZmp6an9Lv4pMQLkHtqOL5MM3N23J12vSLq7_ly3_oSZKosIyQ0CAMo3Zi1nlzwQqlIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Ellis, Morgan M. ; Jones, Lamont R. ; Siddiqui, Farzan ; Sunkara, Pranit R. ; Ozog, David M.</creator><creatorcontrib>Ellis, Morgan M. ; Jones, Lamont R. ; Siddiqui, Farzan ; Sunkara, Pranit R. ; Ozog, David M.</creatorcontrib><description>BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective. OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuvant interventions (triple therapy). MATERIALS AND METHODSSystematic literature review and meta-analysis of combination treatment for keloids. RESULTSAfter full-text review, we included 60 articles representing 5,547 keloids5,243 received dual therapy, 259 received triple therapy, and 45 received quadruple therapy (the latter 2 groups were combined for analysis). The difference in recurrence rates between dual (19%) and triple therapy (11.2%) was not significant (p = .343). However, the difference in recurrence rates between dual therapy using surgery and radiation (18.7%) and triple therapy using surgery, radiation, and a third intervention (7.7%) was significant (p = .002). The differences for surgery and intralesional triamcinolone (TAC) showed trends toward significance, because keloids treated with dual therapy (21.7%) had a higher recurrence rate than those treated with triple therapy comprised of surgery, TAC, and another intervention (13.7%; p = .099). CONCLUSIONTriple therapy using surgery plus radiation and/or TAC as one of the adjuvant treatment modalities may achieve the lowest recurrence rates for keloids.</description><identifier>ISSN: 1076-0512</identifier><identifier>EISSN: 1524-4725</identifier><identifier>DOI: 10.1097/DSS.0000000000002362</identifier><identifier>PMID: 32224709</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Anti-Inflammatory Agents - therapeutic use ; Chemotherapy, Adjuvant ; Combined Modality Therapy - methods ; Dermatologic Surgical Procedures ; Humans ; Injections, Intralesional ; Keloid - therapy ; Radiotherapy, Adjuvant ; Recurrence ; Triamcinolone - therapeutic use</subject><ispartof>Dermatologic surgery, 2020-08, Vol.46 (8), p.1054-1059</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>2020 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4012-5823c1c5a069e22289d0d1e00642a03443c11ec9b7da927b24b877e75ecb3f2f3</citedby><cites>FETCH-LOGICAL-c4012-5823c1c5a069e22289d0d1e00642a03443c11ec9b7da927b24b877e75ecb3f2f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32224709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ellis, Morgan M.</creatorcontrib><creatorcontrib>Jones, Lamont R.</creatorcontrib><creatorcontrib>Siddiqui, Farzan</creatorcontrib><creatorcontrib>Sunkara, Pranit R.</creatorcontrib><creatorcontrib>Ozog, David M.</creatorcontrib><title>The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis</title><title>Dermatologic surgery</title><addtitle>Dermatol Surg</addtitle><description>BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective. OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuvant interventions (triple therapy). MATERIALS AND METHODSSystematic literature review and meta-analysis of combination treatment for keloids. RESULTSAfter full-text review, we included 60 articles representing 5,547 keloids5,243 received dual therapy, 259 received triple therapy, and 45 received quadruple therapy (the latter 2 groups were combined for analysis). The difference in recurrence rates between dual (19%) and triple therapy (11.2%) was not significant (p = .343). However, the difference in recurrence rates between dual therapy using surgery and radiation (18.7%) and triple therapy using surgery, radiation, and a third intervention (7.7%) was significant (p = .002). The differences for surgery and intralesional triamcinolone (TAC) showed trends toward significance, because keloids treated with dual therapy (21.7%) had a higher recurrence rate than those treated with triple therapy comprised of surgery, TAC, and another intervention (13.7%; p = .099). CONCLUSIONTriple therapy using surgery plus radiation and/or TAC as one of the adjuvant treatment modalities may achieve the lowest recurrence rates for keloids.</description><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Chemotherapy, Adjuvant</subject><subject>Combined Modality Therapy - methods</subject><subject>Dermatologic Surgical Procedures</subject><subject>Humans</subject><subject>Injections, Intralesional</subject><subject>Keloid - therapy</subject><subject>Radiotherapy, Adjuvant</subject><subject>Recurrence</subject><subject>Triamcinolone - therapeutic use</subject><issn>1076-0512</issn><issn>1524-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkN9u0zAUh60JxP7xBhPyC2Q7PnHqhLtqdGzaJtBariPHOaEeTlLZzkqfgNeepwJCXIBv7CN_30_2j7EzAecCKnXxYbk8hz8W5jM8YEeiQJlJhcWrdAY1y6AQeMiOQ3gEEFjl8IYd5ogoFVRH7MdqTXzRddZos-Njx5eT_5oGxxffjQ12HPhnNwU-bx-nJz1Efj-5aPuxTURSvd5YCtwOPKaclScde0pUCrolN9o2vOdzvtyFSL2O1vAHerK05Xpo-T1Fnc0H7XbBhlP2utMu0Nuf-wn7crVYXV5nd58-3lzO7zIj0-uzosTcCFNomFWUPlFWLbSCAGYSNeRSpltBpmpUqytUDcqmVIpUQabJO-zyEyb3ucaPIXjq6o23vfa7WkD90mudeq3_7jVp7_baZmp6an9Lv4pMQLkHtqOL5MM3N23J12vSLq7_ly3_oSZKosIyQ0CAMo3Zi1nlzwQqlIQ</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Ellis, Morgan M.</creator><creator>Jones, Lamont R.</creator><creator>Siddiqui, Farzan</creator><creator>Sunkara, Pranit R.</creator><creator>Ozog, David M.</creator><general>Lippincott Williams &amp; Wilkins</general><general>by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200801</creationdate><title>The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis</title><author>Ellis, Morgan M. ; Jones, Lamont R. ; Siddiqui, Farzan ; Sunkara, Pranit R. ; Ozog, David M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4012-5823c1c5a069e22289d0d1e00642a03443c11ec9b7da927b24b877e75ecb3f2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Chemotherapy, Adjuvant</topic><topic>Combined Modality Therapy - methods</topic><topic>Dermatologic Surgical Procedures</topic><topic>Humans</topic><topic>Injections, Intralesional</topic><topic>Keloid - therapy</topic><topic>Radiotherapy, Adjuvant</topic><topic>Recurrence</topic><topic>Triamcinolone - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ellis, Morgan M.</creatorcontrib><creatorcontrib>Jones, Lamont R.</creatorcontrib><creatorcontrib>Siddiqui, Farzan</creatorcontrib><creatorcontrib>Sunkara, Pranit R.</creatorcontrib><creatorcontrib>Ozog, David M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Dermatologic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ellis, Morgan M.</au><au>Jones, Lamont R.</au><au>Siddiqui, Farzan</au><au>Sunkara, Pranit R.</au><au>Ozog, David M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis</atitle><jtitle>Dermatologic surgery</jtitle><addtitle>Dermatol Surg</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>46</volume><issue>8</issue><spage>1054</spage><epage>1059</epage><pages>1054-1059</pages><issn>1076-0512</issn><eissn>1524-4725</eissn><abstract>BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective. OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuvant interventions (triple therapy). MATERIALS AND METHODSSystematic literature review and meta-analysis of combination treatment for keloids. RESULTSAfter full-text review, we included 60 articles representing 5,547 keloids5,243 received dual therapy, 259 received triple therapy, and 45 received quadruple therapy (the latter 2 groups were combined for analysis). The difference in recurrence rates between dual (19%) and triple therapy (11.2%) was not significant (p = .343). However, the difference in recurrence rates between dual therapy using surgery and radiation (18.7%) and triple therapy using surgery, radiation, and a third intervention (7.7%) was significant (p = .002). The differences for surgery and intralesional triamcinolone (TAC) showed trends toward significance, because keloids treated with dual therapy (21.7%) had a higher recurrence rate than those treated with triple therapy comprised of surgery, TAC, and another intervention (13.7%; p = .099). CONCLUSIONTriple therapy using surgery plus radiation and/or TAC as one of the adjuvant treatment modalities may achieve the lowest recurrence rates for keloids.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>32224709</pmid><doi>10.1097/DSS.0000000000002362</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1076-0512
ispartof Dermatologic surgery, 2020-08, Vol.46 (8), p.1054-1059
issn 1076-0512
1524-4725
language eng
recordid cdi_crossref_primary_10_1097_DSS_0000000000002362
source MEDLINE; Journals@Ovid Complete
subjects Anti-Inflammatory Agents - therapeutic use
Chemotherapy, Adjuvant
Combined Modality Therapy - methods
Dermatologic Surgical Procedures
Humans
Injections, Intralesional
Keloid - therapy
Radiotherapy, Adjuvant
Recurrence
Triamcinolone - therapeutic use
title The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T12%3A55%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Efficacy%20of%20Surgical%20Excision%20Plus%20Adjuvant%20Multimodal%20Therapies%20in%20the%20Treatment%20of%20Keloids:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=Dermatologic%20surgery&rft.au=Ellis,%20Morgan%20M.&rft.date=2020-08-01&rft.volume=46&rft.issue=8&rft.spage=1054&rft.epage=1059&rft.pages=1054-1059&rft.issn=1076-0512&rft.eissn=1524-4725&rft_id=info:doi/10.1097/DSS.0000000000002362&rft_dat=%3Cpubmed_cross%3E32224709%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32224709&rfr_iscdi=true